Details of a statewide effort in Ohio were revealed at the SMFM conference that demonstrated the successful reduction in the number of scheduled near-term births without a medical or obstetric indication from 1 in 4 to less than 1 in 20.
Jay Iams, MD, for the Ohio Perinatal Quality Collaborative unveiled the details of a statewide effort in Ohio that successfully reduced the number of scheduled near-term births-either by cesarean delivery or induction of labor-without a medical or obstetric indication from 1 in 4 to less than 1 in 20 (P<0.05).
Using a variety of education and intervention tools, 20 level 2 and 3 maternity hospitals-which handle about half of the state's births-shared their methods during the 14-month study. As a result, the rate of scheduled births between 36.1 and 38.6 weeks without medical necessity declined from 25% to below 5%. Inductions without medical necessity also declined from a 12-month mean of 13% to 8% (P<.0027), and fewer infants born at 36 to 38 weeks' gestation were admitted to the neonatal intensive care unit.
The Ohio Perinatal Quality Collaborative; Iams J. A statewide initiative to reduce scheduled births without appropriate indication [abstract]. Am J Obstet Gynecol. 2009;201(6 suppl):S19. Abstract 33.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More